Other experimental approaches targeting MDSCs in the concept of cancer include the blockade of accumulation pathways like the CCL/CCR2 axis and IL-8/CXCR1/2 interactions, which may hinder the trafficking of MDSCs to the TME and inhibit extravasation [32]. Here, CXCR1 is linked to cancer.